Rallybio Corporation — Cash Flow (NASDAQ:RLYB) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 45.53 M57.28 M60.27 M49.28 M 35 M Cash from investing activities 2.33 M112.17 M27.66 M33.49 M 41.77 M Cash from financing activities 82.97 M51.08 M143 K5.2 M 28 K Free cash flow 45.2 M57.23 M60.25 M49.28 M 35 M

Noticias

Lieber, director financiero de Rallybio, vende acciones por 3.992 dólares

CFO de Rallybio vende acciones por $3,992

Lieber, Rallybio CFO, sells $3992 in shares

Rallybio reports positive phase 1 results for subcutaneous C5 inhibitor

Rallybio announces one-for-eight reverse stock split effective Feb 6

Upcoming Stock Splits This Week (February 2 to February 6) – Stay Invested - TipRanks.com

Rallybio implementará un split inverso de acciones de 1 por 8 a partir del 6 de febrero

Rallybio implementará división inversa de acciones 1 por 8 desde el 6 de febrero

Rallybio to implement 1-for-8 reverse stock split effective February 6

Rallybio completa la dosificación del primer cohorte en el estudio del inhibidor C5 RLYB116

Rallybio completes first cohort dosing in RLYB116 C5 inhibitor study

Here's Why Shares in Recursion Pharmaceuticals Surged Today